Fundraising Fox
Protean Biodiagnostics
Orlando, US · Founded 2017 · Florida corporation
Find your way into Protean Biodiagnostics
Sign up to see every warm intro you have to Protean Biodiagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Protean Biodiagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Protean BioDiagnostics offers Protean MAPS, a cancer profiling and diagnostics platform that combines oncology tests with decision-support tools, telemedicine, virtual tumor boards, and AI-based clinical trial matching. It serves oncologists seeking precision oncology guidance across all cancer types.
Founders & leadership
Protean Biodiagnostics was founded in 2017 by Anthony M. Magliocco and Dr. Anthony Magliocco, MD FRCPC FCAP.
AM
Anthony M. MaglioccoFounder and PresidentAnthony M. Magliocco is President and CEO of Protean Biodiagnostics, a precision oncology company offering cancer profiling and diagnostics tools. He brings expertise in pathology and focus on companion diagnostics and next-generation sequencing for oncology.
DA
Dr. Anthony Magliocco, MD FRCPC FCAPPresident and CEO; founder
Board
FM
Frank MorsaniBoard director
AC
Anees ChagparBoard director
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 2 of 4 rounds · 2019–2023
▶$6MofferedDec 2023 · Other Health CareRule 506(b)
▶$6MofferedDec 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ronen IsraelDirector
- Frank MorsaniDirector
- Susan LeeExecutive Officer
- Anees ChagparDirector
- Violet JamesonDirector
- Anthony Martin MaglioccoExecutive Officer, Director
- Offering amount
- $6M
- Minimum investment
- $50K
- Sales commissions
- $360K
- Proceeds to insiders
- $250K
- Placement agents
- Tangent Capital Partners, LLC
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$1.4MraisedMay 2021 · 12 investors · Other Health CareRule 506(b)
▶$1.4MraisedMay 2021 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Anees ChagparDirector
- Frank MorsaniDirector
- Anthony M. MaglioccoExecutive Officer, Director, Promoter
- Offering amount
- $1.7M
- Amount sold
- $1.4M
- Minimum investment
- $30K
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
▶$1.5MofferedMay 2021 · Other Health CareRule 506(b)
▶$1.5MofferedMay 2021 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frank MorsaniDirector
- Anthony M. MaglioccoExecutive Officer, Director, Promoter
- Anees ChagparDirector
- Offering amount
- $1.5M
- Minimum investment
- $30K
- Placement agents
- Eastgate Securities, LLC
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
▶$330KraisedJun 2019 · 4 investors · Other Health CareRule 506(b)
▶$330KraisedJun 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frank MorsaniDirector
- Anthony M. MaglioccoExecutive Officer, Director, Promoter
- Anees ChagparDirector
- Offering amount
- $800K
- Amount sold
- $330K
- First sale
- Jun 2019
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
CancerresearchukCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
MD Anderson Cancer CenterUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Companies working in the same space as Protean Biodiagnostics.
Frequently asked questions
- What does Protean Biodiagnostics do?
- Protean BioDiagnostics offers Protean MAPS, a cancer profiling and diagnostics platform that combines oncology tests with decision-support tools, telemedicine, virtual tumor boards, and AI-based clinical trial matching. It serves oncologists seeking precision oncology guidance across all cancer types.
- Who founded Protean Biodiagnostics?
- Protean Biodiagnostics was founded by Anthony M. Magliocco, Dr. Anthony Magliocco, MD FRCPC FCAP in 2017.
- How much funding has Protean Biodiagnostics raised?
- Protean Biodiagnostics has disclosed $1.8M raised across 2 of its 4 known rounds.
- Where is Protean Biodiagnostics headquartered?
- Protean Biodiagnostics is headquartered in Orlando, US.